Disordered respiration as a levodopa-induced dyskinesia in Parkinson's disease

Movement Disorders

Volumn 17, Issue 3, 2002, Pages 524-527

  Rice, J E ^a   Antic, R ^a   Thompson, Philip D ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

L dopa; Parkinson's disease; Respiratory dyskinesia

Indexed keywords

APOMORPHINE; CARBIDOPA PLUS LEVODOPA; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AGED; APNEA; ARTICLE; BREATHING DISORDER; BREATHING PATTERN; BREATHING RATE; CASE REPORT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; DYSPNEA; HUMAN; LUNG ALVEOLUS HYPOVENTILATION; MALE; OROFACIAL DYSKINESIA; PARKINSON DISEASE; PRIORITY JOURNAL; RESPIRATION CENTER; RESPIRATION CONTROL; TACHYPNEA;

AGED; ANTIPARKINSON AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; MALE; PARKINSON DISEASE; RESPIRATION DISORDERS;

EID: 0036589898     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10072     Document Type: Article

References (18)

1. Brown LK. Respiratory dysfunction in Parkinson's disease. Clin Chest Med 1994;15:715-727.
2. Nakano KK, Bass H, Tyler HR. Levodopa in Parkinson's disease: effect on pulmonary function. Arch Intern Med 1972;130:346-348.
3. Tzelepis GE, McCool FD, Friedman JH, Hoppin FG. Respiratory dysfunction in Parkinson's disease. Am Rev Respir Dis 1988;138: 266-271.
4. De Bruin PFC, de Bruin VMS, Lees AJ, Pride NB. Effects of treatment on airway dynamics and respiratory muscle strength in Parkinson's disease. Am Rev Respir Dis 1993;148:1576-1580.
5. Hovestadt A, Bogaard JM, Meewaldt JD, van der Meché FGA, Stigt J. Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 1989;52:329-333.
6. Apps MCP, Sheaff PC, Ingram DA. Kennard C, Empey DW. Respiration and sleep in Parkinson's disease. J Neurol Neurosurg Psychiatry 1985;48:1240-1245.
7. Nutt JG. Levodopa-induced dyskinesias: review, observations, and speculations. Neurology 1990;40:340-345.
8. Vidailhet M, Bonnet AM, Marconi R, Durif F Agid Y. The phenomenology of L-dopa-induced dyskinesias in Parkinson's disease. Mov Disord 1999;14(Suppl. 1):13-18.
9. Sacks OW, Kohl M, Schwartz W, Messeloff C. Side-effects of L-dopa in post-encephalitic parkinsonism. Lancet 1970;1:1006.
10. Weiner WJ, Goetz CG, Nausieda PA, Klawans HL. Respiratory dyskinesias: extrapyramidal dysfunction and dyspnoea. Ann Intern Med 1978;88:327-331.
11. De Keyser J, Vincken W, L-dopa-induced respiratory disturbance in Parkinson's disease suppressed by tiapride. Neurology 1985;35: 235-237.
12. Jankovic J, Nour F. Respiratory dyskinesias in Parkinson's disease. Neurology 1986;36:303-304.
13. Gardner WN, Langdon N, Parkes JD. Breathing in Parkinson's disease. Adv Neurol 1987:45;271-274.
14. Ilson J, Braun N, Fahn S. Respiratory fluctuations in Parkinson's disease [abstract]. Neurology 1983; 33(Suppl. 2):113.
15. Fraser RS, Müller NL, Colman N, Par-ace PD. Diagnosis of disease of the Chest. 4th ed. The control of breathing. Philadelphia: WB Saunders; 1999. p 235-245.
16. Serebrovskaya T, Karacan I, Mankovskaya I, Bernardi L, Passino C, Appenzeller O. Hypoxic ventilatory response and gas exchange in patients with Parkinson's disease. Respiration 1998;65:28-33.
17. Mueller RA, Lundberg DBA, Breese GR, Hedner J, Hedner T, Jonason J. The neuropharmacology of respiratory control. Pharmacol Rev 1982;34:255-285.
18. Purdy A, Hahn A, Barnett HJM, Bratty P, Ahmad D, Lloyd KG, McGeer EG, Perry TL. Familial fatal parkinsonism with alveolar hypoventilation and mental depression. Ann Neurol 1979;6:525-531.